Article    Table of Contents                    Full Text of this article    PDF of this article (PDFs free after 6 months)    Figures/Tables List    Related articles in Annals  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    O'Connor, P. G.    Fiellin, D. A.    Related Articles in PubMed    PubMed Citation    PubMed

REVIEW

Pharmacologic Treatment of Heroin-Dependent Patients

Patrick G. O'Connor, MD, MPH, and David A. Fiellin, MD

4 July 2000 | Volume 133 Issue 1 | Pages 40-54

Patients with heroin dependence frequently present to internists and other physicians for heroin-related medical, psychiatric, and behavioral health problems and often seek help with reducing their heroin use. Thus, physicians should be familiar with the identification and diagnosis of heroin dependence in their patients and be able to initiate treatment of heroin dependence both directly and by referral. Recent research has provided much information concerning effective pharmacologically based treatment approaches for managing opioid withdrawal and helping patients to remain abstinent. Methadone maintenance and newer approaches using L- acetylmethadol and buprenorphine seem to be particularly effective in promoting relapse prevention. Although these treatments are currently provided in special drug treatment settings, recent and ongoing research indicates that the physician's office may be an effective alternative site for these treatments.

Author and Article Information

From Yale University School of Medicine and Yale–New Haven Hospital Primary Care Center, New Haven, Connecticut.

Grant Support: Dr. Fiellin is supported by the National Institute on Drug Abuse Physician Scientist Award (K12 DA00167).

Requests for Single Reprints: Patrick O'Connor, MD, MPH, Yale University School of Medicine, 333 Cedar Street, Box 208025, New Haven, CT 06520.

Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints{at}mail.acponline.org.

Current Author Addresses: Drs. O'Connor and Fiellin: Yale University School of Medicine, 333 Cedar Street, Box 208025, New Haven, CT 06520.

Related articles in Annals:

Letters
Treatment of Heroin Dependence
Joseph O. Merrill AND Ron Jackson

Annals 2001 134: 165-166. [Full Text]  

Letters
Treatment of Heroin Dependence
Mark H. Hyman

Annals 2001 134: 714. [Full Text]  

Letters
Treatment of Heroin Dependence
Patrick G. O'Connor AND David A. Fiellin

Annals 2001 134: 714-715. [Full Text]  

This article has been cited by other articles:

				C. P. Thomas, S. Reif, S. Haq, S. S. Wallack, A. Hoyt, and G. A. Ritter Use of Buprenorphine for Addiction Treatment: Perspectives of Addiction Specialists and General Psychiatrists Psychiatr Serv, August 1, 2008; 59(8): 909 - 916. [Abstract] [Full Text] [PDF]

				S. K. Gupta, E. Sellers, E. Somoza, L. Angles, K. Kolz, and D. L. Cutler The Effect of Multiple Doses of Peginterferon alfa-2b on the Steady-State Pharmacokinetics of Methadone in Patients With Chronic Hepatitis C Undergoing Methadone Maintenance Therapy J. Clin. Pharmacol., May 1, 2007; 47(5): 604 - 612. [Abstract] [Full Text] [PDF]

				M. B. Kushel and C. Miaskowski End-of-Life Care for Homeless Patients: "She Says She Is There to Help Me in Any Situation" JAMA, December 27, 2006; 296(24): 2959 - 2966. [Abstract] [Full Text] [PDF]

				D. P. Alford, P. Compton, and J. H. Samet Acute Pain Management for Patients Receiving Maintenance Methadone or Buprenorphine Therapy Ann Intern Med, January 17, 2006; 144(2): 127 - 134. [Abstract] [Full Text] [PDF]

				P. G. O'Connor Methods of Detoxification and Their Role in Treating Patients With Opioid Dependence JAMA, August 24, 2005; 294(8): 961 - 963. [Full Text] [PDF]

				K. E. Watkins, S. B. Hunter, M. A. Burnam, H. A. Pincus, and G. Nicholson Review of Treatment Recommendations for Persons With a Co-occurring Affective or Anxiety and Substance Use Disorder Psychiatr Serv, August 1, 2005; 56(8): 913 - 926. [Abstract] [Full Text] [PDF]

				M. J. Shelton, D. Cloen, R. DiFrancesco, C. S. Berenson, A. Esch, P. J. de Caprariis, B. Palic, J. L. Schur, C. J. L. Bugge, A. Ljungqvist, et al. The Effects of Once-Daily Saquinavir/Minidose Ritonavir on the Pharmacokinetics of Methadone J. Clin. Pharmacol., March 1, 2004; 44(3): 293 - 304. [Abstract] [Full Text] [PDF]

				T. R. Kosten and P. G. O'Connor Management of Drug and Alcohol Withdrawal N. Engl. J. Med., May 1, 2003; 348(18): 1786 - 1795. [Full Text] [PDF]

				R. E. Ferner, A. M. Daniels, D. A. Fiellin, and P. G. O'Connor Office-Based Treatment of Opioid-Dependent Patients N. Engl. J. Med., January 2, 2003; 348(1): 81 - 82. [Full Text] [PDF]

				S W Borron, C Monier, P Risede, and F J Baud Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat Human and Experimental Toxicology, November 1, 2002; 21(11): 599 - 605. [Abstract] [PDF]

				D. A. Fiellin and P. G. O'Connor New Federal Initiatives To Enhance the Medical Treatment of Opioid Dependence Ann Intern Med, October 15, 2002; 137(8): 688 - 692. [Abstract] [Full Text] [PDF]

				D. A. Fiellin and P. G. O'Connor Office-Based Treatment of Opioid-Dependent Patients N. Engl. J. Med., September 12, 2002; 347(11): 817 - 823. [Full Text] [PDF]

				F. Caputo, G. Addolorato, M. Domenicali, A. Mosti, M. Viaggi, F. Trevisani, G. Gasbarrini, M. Bernardi, and G. F. Stefanini SHORT-TERM METHADONE ADMINISTRATION REDUCES ALCOHOL CONSUMPTION IN NON-ALCOHOLIC HEROIN ADDICTS Alcohol Alcohol., March 1, 2002; 37(2): 164 - 168. [Abstract] [Full Text] [PDF]

				D. A. Fiellin, P. G. O'Connor, M. Chawarski, J. P. Pakes, M. V. Pantalon, and R. S. Schottenfeld Methadone Maintenance in Primary Care: A Randomized Controlled Trial JAMA, October 10, 2001; 286(14): 1724 - 1731. [Abstract] [Full Text] [PDF]

				Y. Oda and E. D. Kharasch Metabolism of Methadone and levo-alpha -Acetylmethadol (LAAM) by Human Intestinal Cytochrome P450 3A4 (CYP3A4): Potential Contribution of Intestinal Metabolism to Presystemic Clearance and Bioactivation J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1021 - 1032. [Abstract] [Full Text] [PDF]

				D. A. Fiellin, R. A. Rosenheck, and T. R. Kosten Office-Based Treatment for Opioid Dependence: Reaching New Patient Populations Am J Psychiatry, August 1, 2001; 158(8): 1200 - 1204. [Full Text] [PDF]

				Harm reduction: closing the distance: Can. Med. Assoc. J., August 1, 2001; 165(4): 389 - 389. [Full Text] [PDF]

				La reduction des dommages : refermer l'ecart Can. Med. Assoc. J., August 1, 2001; 165(4): 391 - 391. [Full Text] [PDF]

				M. Koch and P. Banys Liver Transplantation and Opioid Dependence JAMA, February 28, 2001; 285(8): 1056 - 1058. [Abstract] [Full Text] [PDF]

				B. Stimmel, T. V. Reese, R. E. Johnson, E. C. Strain, G. E. Bigelow, and P. G. O'Connor Treating Opioid Dependence N. Engl. J. Med., February 15, 2001; 344(7): 530 - 531. [Full Text] [PDF]

				J. O. Merrill and R. Jackson Treatment of Heroin Dependence Ann Intern Med, January 16, 2001; 134(2): 165 - 166. [Full Text] [PDF]

				A. T. McLellan, D. C. Lewis, C. P. O'Brien, and H. D. Kleber Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation JAMA, October 4, 2000; 284(13): 1689 - 1695. [Abstract] [Full Text] [PDF]